<Disease><Name>MUCOPOLYSACCHARIDOSIS I-H; HURLER SYNDROME (MPS1-H)</Name><Synonym>MPS1-H</Synonym><OMIM><Number>607014</Number><URL>http://omim.org/entry/607014</URL></OMIM><Orphanet><Number>93473</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=93473</URL></Orphanet><Protein><Number>Alpha-L-iduronidase</Number><URL>http://www.uniprot.org/uniprot/P35475</URL></Protein><ExPASy><Number>3.2.1.76</Number><URL>http://enzyme.expasy.org/EC/3.2.1.76</URL></ExPASy><Gene>4p16.3</Gene><ICD>E76.0</ICD><Summary>rare (1:100.000);autosomal recessive</Summary><Symptoms><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3676</id><symptom>cardiomyopathy, dilated</symptom><category>CARDIOVASCULAR SYSTEM | CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>2247</id><symptom>contractures, joints</symptom><category>GENERAL TOPICS | SKELETAL DEFECT</category></symtomp><symtomp><id>2448</id><symptom>corneal clouding</symptom><category>EYES</category></symtomp><symtomp><id>2124</id><symptom>corneal deposits</symptom><category>EYES</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2302</id><symptom>dysostosis multiplex</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>1799</id><symptom>flat depressed nasal bridge (saddle nose)</symptom><category>HEAD</category></symtomp><symtomp><id>2217</id><symptom>glaucoma</symptom><category>EYES</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3371</id><symptom>hirsutism</symptom><category>ENDOCRINE SYSTEM</category></symtomp><symtomp><id>1960</id><symptom>hydrocephalus</symptom><category>HEAD | NERVOUS SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3222</id><symptom>hypertrichosis</symptom><category>SKIN</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1910</id><symptom>inguinal hernia</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2304</id><symptom>joint stiffness</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1852</id><symptom>macroglossia, large/protuding tongue</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3780</id><symptom>mongolian spots</symptom><category>SKIN</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2340</id><symptom>normal at birth</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2353</id><symptom>obstructive airway disease / asthma</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4071</id><symptom>otitis media, recurrent</symptom><category>EARS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1859</id><symptom>Teeth: generalized defect or abnormalities</symptom><category>HEAD</category></symtomp><symtomp><id>1909</id><symptom>umbilical hernia</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>7935</id><title>Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha-L-iduronidase determinations on dr</title><author>Langan TJ,</author><journal>JIMD Rep</journal><year>2020</year><book /><volume>52</volume><number>1</number><pages>35-42</pages><co_aut>et al.</co_aut></literature><literature><id>7988</id><title>Screening for Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis</title><author>Patel P,</author><journal>J Child Neurol</journal><year>2020</year><book /><volume>35</volume><number>6</number><pages>410-417</pages><co_aut>et al.</co_aut></literature><literature><id>4810</id><title>Open issues in Mucopolysaccharidosis type I-Hurler</title><author>Parini R,</author><journal>Orphanet J Rare Dis</journal><year>2017</year><book /><volume>12</volume><number>1</number><pages>112</pages><co_aut>et al.</co_aut></literature><literature><id>5444</id><title>Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome</title><author>Eisengart JB,</author><journal>Mol Genet Metab Rep</journal><year>2017</year><book /><volume>13</volume><number>0</number><pages>64-68</pages><co_aut>et al.</co_aut></literature><literature><id>4813</id><title>Mucopolysaccharidosis Type I</title><author>Clarke LA</author><journal>GeneReviews&#174; [Internet]</journal><year>2016</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>4811</id><title>Mucopolysaccharidosis type I</title><author>Wraith JE,</author><journal>Pediatr Endocrinol Rev Suppl</journal><year>2014</year><book /><volume>1</volume><number>0</number><pages>102-106</pages><co_aut>Jones S</co_aut></literature><literature><id>4501</id><title>Mongolian spots: How important are they?</title><author>Gupta D,</author><journal>World J Clin Cases</journal><year>2013</year><book /><volume>1</volume><number>8</number><pages>230-232</pages><co_aut>Thappa DM</co_aut></literature><literature><id>4812</id><title>Enzyme replacement therapy with laronidase (Aldurazyme(&#174;)) for treating mucopolysaccharidosis type I</title><author>Jameson E,</author><journal>Cochrane Database Syst Rev</journal><year>2013</year><book /><volume>11</volume><number>0</number><pages /><co_aut>Jones S, Wraith JE</co_aut></literature><literature><id>5080</id><title>Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options</title><author>Oussoren E,</author><journal>Biochim Biophys Acta</journal><year>2011</year><book /><volume>1812</volume><number>11</number><pages>1542-1556</pages><co_aut>et al.</co_aut></literature><literature><id>1800</id><title>Laronidase treatment of mucopolysaccharidosis I</title><author>Wraith EJ</author><journal>BioDrugs</journal><year>2005</year><book /><volume>19</volume><number>1</number><pages>1-7</pages><co_aut>et al.</co_aut></literature><literature><id>1870</id><title>Tandem Mass Spectrometric Analysis of Dried Blood Spots for Screening of Mucopolysaccharidosis I in Newborns</title><author>Wang D</author><journal>Clin Chem</journal><year>2005</year><book /><volume>51</volume><number>5</number><pages>898-900</pages><co_aut>et al.</co_aut></literature><literature><id>1801</id><title>Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I</title><author>Brooks DA</author><journal>Expert Opin Biol Ther</journal><year>2002</year><book /><volume>2</volume><number>8</number><pages>967-976</pages><co_aut /></literature><literature><id>57</id><title>The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leu</title><author>Krivit W</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>398-412</pages><co_aut>Lockman LA, Watkins PA, Hirsch J, Shapiro EG</co_aut></literature><literature><id>102</id><title>The mucopolysaccharidoses</title><author>Neufeld EF</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2465-2494</pages><co_aut>M&#252;nzer J</co_aut></literature><literature><id>258</id><title>The presenting features of mucopolysaccharidosis type IH (Hurler syndrome)</title><author>Cleary MA</author><journal>Acta Paediatr</journal><year>1995</year><book /><volume>84</volume><number>3</number><pages>337-339</pages><co_aut>Wraith JE</co_aut></literature></Literatures></Disease>